Our Faculty

Scientists collaberate while working at a computer

With 130+ physician and research faculty members, our division is one of the largest in the country. Our faculty members participate in every facet of cancer prevention, patient care, survivorship, mentorship, and research on cancer and related diseases.

This is unpublished

Physician & Research Faculty Profiles 

 

Notable Faculty achievements

  • Faculty have been elected by their peers to lead the American Society for Clinical Oncology, the American Society of Hematology, the American Association for Cancer Research, the American Society for Transplantation and Cellular Therapy, the World Marrow Donor Association, the American Society for Blood and Marrow Transplantation, and the National Cancer Institute’s Leukemia and Lymphoma Steering Committees.
  • Many faculty members have been chosen to determine standardized cancer care guidelines through the National Comprehensive Cancer Network.
  • Faculty have been editors-in-chief of major textbooks and professional journals.
  • Faculty published more than 400 peer-reviewed journal articles in 2019.
  • Our faculty continue to be chosen by their peers for Seattle Magazine’s Best Doctors list. In 2022 twelve faculty members were honored.
  • Sixteen faculty members hold endowed chairs. 
  • Our division was founded by Dr. E. Donnall Thomas, who received the Nobel Prize for his work in developing bone marrow transplantation.

Faculty news

Moritz Stolla is 2025 Hall of Fame Inductee
The AABB Hall of Fame recognizes a prestigious and select group of Foundation grant recipients who leveraged their early-career grant funding into successful careers in transfusion medicine or biotherapies and who demonstrated exemplary leadership
Evaluating the Impact of IVIg on Elranatamab Outcomes in Relapsed or Refractory Multiple Myeloma: A Real-World Analysis
Dr. Andrew Portuguese is PI on a research grant from Pfizer, focused on real-world elranatamab outcomes in multiple myeloma.
Heather Parsons to lead Fred Hutch’s breast cancer initiatives
Parsons has been awarded an endowed chair to study novel markers for cancer in blood serum.